R1	Has_qualifier Arg1:T1 Arg2:T2	
R2	Has_negation Arg1:T6 Arg2:T7	
R3	Has_qualifier Arg1:T5 Arg2:T6	
R4	multi Arg1:T6 Arg2:T8	
*	OR T10 T9
R5	Has_qualifier Arg1:T10 Arg2:T11	
R7	Has_negation Arg1:T17 Arg2:T18	
R8	Has_index Arg1:T19 Arg2:T20	
R9	Has_temporal Arg1:T17 Arg2:T19	
R10	AND Arg1:T15 Arg2:T17	
*	OR T15 T22 T21
R11	Has_index Arg1:T23 Arg2:T24	
R12	causal Arg1:T27 Arg2:T25	
R13	Has_temporal Arg1:T27 Arg2:T26	
R14	Has_value Arg1:T28 Arg2:T29	
R15	Has_value Arg1:T30 Arg2:T31	
R16	Has_value Arg1:T32 Arg2:T33	
R17	Has_value Arg1:T34 Arg2:T35	
R18	Has_value Arg1:T39 Arg2:T40	
R19	Has_value Arg1:T43 Arg2:T44	
R20	Has_value Arg1:T45 Arg2:T46	
R6	Has_temporal Arg1:T15 Arg2:T23	
R21	Has_negation Arg1:T15 Arg2:T16	
*	OR T3 T4
R22	Has_index Arg1:T49 Arg2:T50	
R23	Has_temporal Arg1:T39 Arg2:T49	
R24	Has_value Arg1:T36 Arg2:T35	
R25	Has_value Arg1:T37 Arg2:T35	
R26	Has_temporal Arg1:T41 Arg2:T49	
R27	Has_temporal Arg1:T42 Arg2:T49	
R28	Has_temporal Arg1:T43 Arg2:T49	
R29	Has_temporal Arg1:T45 Arg2:T49	
T1	Condition 7 15	melanoma
T2	Qualifier 0 6	HLA-A2
T3	Condition 40 53;68 78	loco-regional metastasis
T4	Condition 57 78	lymph node metastasis
T5	Condition 80 95	transit nodules
T6	Qualifier 100 121	surgically resectable
T7	Negation 96 99	not
T8	Procedure 100 110	surgically
T9	Condition 147 166	visceral metastasis
T10	Condition 134 143;156 166	cutaneous metastasis
T11	Qualifier 123 133	measurable
T13	Observation 200 214	MART-1 antigen
T14	Observation 192 199;207 214	Melan-A antigen
T15	Procedure 220 232	chemotherapy
T16	Negation 217 219	No
T17	Drug 255 263	Deticene
T18	Negation 244 254	except for
T19	Temporal 269 308	before the first T cell clones infusion
T20	Reference_point 276 308	the first T cell clones infusion
T21	Procedure 313 325	radiotherapy
T22	Procedure 329 342	immunotherapy
T23	Temporal 343 378	in the last 4 weeks before infusion
T24	Reference_point 370 378	infusion
T25	Condition 390 398	melanoma
T26	Temporal 409 428	during the protocol
T27	Procedure 399 408	treatment
T28	Observation 431 446	Life expectancy
T29	Value 457 478	greater than 6 months
T30	Measurement 500 509	Karnowsky
T31	Value 510 525	greater than 80
T32	Measurement 527 531	ECOG
T33	Value 534 543	0, 1 or 2
T34	Measurement 577 580	HIV
T35	Value 564 572	negative
T36	Measurement 591 602	C hepatitis
T37	Measurement 585 586;593 602	B hepatitis
T39	Measurement 658 668	leucocytes
T40	Value 669 692	³ 2000 elements per mm3
T41	Measurement 694 704	hemoglobin
T42	Value 705 715	³ 10.5g/dl
T43	Measurement 717 726	platelets
T44	Value 727 744	³ 100 000 per mm3
T45	Measurement 746 782	phosphatases alcalines transaminases
T46	Value 783 818	£ 1 time 1/2 compared to the normal
T47	Observation 821 844	Signed informed consent
T49	Temporal 627 656	at the beginning of the study
T50	Reference_point 630 656	the beginning of the study
